41 results
Page 2 of 3
6-K
zvla9ls h9a2ucdq8
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
cx66k
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.2
iov5f h1y
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.1
c6g0nwz
24 Oct 16
Bioblast Announces Results of Trehalose Clinical Study
12:00am
424B5
ojoo4rfy
18 Mar 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
ar57kecb
27 Oct 15
Current report (foreign)
12:00am
6-K
EX-99.2
a7gq3jflmr 0g8mohs
27 Oct 15
Current report (foreign)
12:00am
20-F
bztrf7p5hf38j690d
31 Mar 15
Annual report (foreign)
12:00am
6-K
EX-99.1
pfjqar4t36o9
10 Feb 15
Notice of Extraordinary General Meeting of Shareholders
12:00am
6-K
EX-99.1
6mzp va5rbbalb5u
8 Jan 15
Current report (foreign)
12:00am
6-K
EX-99.1
h9in9mhjecjtga3
22 Sep 14
Bio Blast Pharma Announces Initiation of its Canadian OPMD Clinical Study Center at McGill University, Montreal
12:00am
6-K
EX-99.1
po0dp7zfhmj1v30t
17 Sep 14
BioBlast Pharma Announces Preclinical and Clinical Pharmacokinetic Results with Cabaletta, Interim Safety Results from Phase 2/3HOPEMD Study in OPMD
12:00am
424B4
dqqjwoy4ipd
31 Jul 14
Prospectus supplement with pricing info
12:00am